Results 21 to 30 of about 11,541 (279)

Molecular basis of various forms of maple syrup urine disease in Chilean patients

open access: yesMolecular Genetics & Genomic Medicine, 2021
Background Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disorder caused by the deficient activity of the branched‐chain α‐keto acid dehydrogenase (BCKD) enzymatic complex.
Diana Ruffato Resende Campanholi   +12 more
doaj   +2 more sources

Acrodermatitis dysmetabolica secondary to isoleucine deficiency in infant with maple syrup urine disease [PDF]

open access: yesDermatology Reports, 2023
Acrodermatitis dysmetabolica (AD) describes eruptions characterized by the clinical triad of acral dermatitis, diarrhea, and alopecia. AD can be caused by various metabolic disorders one of which is maple syrup urine disease (MSUD). We present a 2-month-
Fares A. Alkhayal   +3 more
doaj   +2 more sources

Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature:Strategies for optimization [PDF]

open access: yesJIMD Reports, 2020
Maple syrup urine disease (MSUD) leads to severe neurological deterioration unless diagnosed early and treated immediately. We have evaluated the effectiveness of 11 years of MSUD newborn screening (NBS) in the Netherlands (screening >72 hours ...
Boelen, Anita   +17 more
core   +2 more sources

Real‐world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid‐free formulas in France and Germany: A retrospective observational study

open access: greenJIMD Reports, 2021
Maple syrup urine disease (MSUD) is a rare inborn metabolic disorder, managed with a strict protein‐restricted diet. At any time or age patients may still experience metabolic decompensations, requiring administration of branched chain amino acid (BCAA ...
Pascale de Lonlay   +14 more
openalex   +3 more sources

Nutritional deficiency dermatitis related to branched-chain amino acid restriction in a child with maple syrup urine disease [PDF]

open access: gold, 2019
We present a one-year-old girl with maple syrup urine disease with dermatitis secondary to the restriction of amino acids as part of the treatment.
Campuzano-García, Andrés Eduardo   +1 more
core   +3 more sources

Two novel mutations in the BCKDHB gene that cause maple syrup urine disease [PDF]

open access: diamondPediatrics and Neonatology, 2018
Background: Maple syrup urine disease (MSUD) is a rare metabolic disorder of autosomal recessive inheritance caused by decreased activity of branched-chain α-ketoacid dehydrogenase complex (BCKD). Mutations in the three genes (BCKDHA, BCKDHB and DBT) are
Bingjuan Han   +4 more
doaj   +2 more sources

CRRT: trattamento della crisi metabolica grave nella maple syrup urine disease

open access: goldGiornale di Clinica Nefrologia e Dialisi, 2018
non ...
Pasquale Fatuzzo   +4 more
doaj   +4 more sources

Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity

open access: yesOrphanet Journal of Rare Diseases, 2020
Background Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disease caused by deficient activity of the branched-chain α-keto acid dehydrogenase (BCKD) enzymatic complex.
Ana Vitoria Barban Margutti   +17 more
doaj   +2 more sources

CLASSIC MAPLE SYRUP URINE DISEASE IN A 46-DAY-OLD BABY: A CASE REPORT [PDF]

open access: goldKhyber Medical University Journal, 2018
Maple syrup urine disease (MSUD) is an inborn error of amino acid metabolism secondary to enzyme defect that breaks down branched-chain amino acid (BCAA).
Zara Idrees   +3 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy